DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

TruAlt Bioenergy Q2 FY27 Results Newspaper Publication

Kalkine India 3 hrs ago·24 Oct 2026, 11:33 am

TruAlt Bioenergy has released its financial results for the second quarter of fiscal year 2027. The company, which focuses on renewable energy solutions, has reported its earnings for this period.

For investors, these results are a key indicator of the company's operational performance and its ability to execute its business strategy in the competitive renewable energy sector. The numbers will help gauge the company's current health and future growth potential.

Market participants should watch for details on revenue growth, margins, and the company's outlook for the upcoming quarters to better understand its trajectory.